Delivery Order SPE2DB20D3103-SPE2DB24FM0E0
Award Date
12/21/23
Potential Completion Date
12/22/23
Potential Value
$6.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,549.79 delivery order is for the supply of Carafate 1 GM Tablets, a pharmaceutical product used for the treatment of ulcers. The contract has an ultimate completion date of December 11, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp...
This federal contract award, identified as SPE2DX15D3020|SPE2DX24FXJZF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of Carafate 1 gram tablets. The contract has a ceiling value of $12,768.88 and a completion date of December 22, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a major pharmaceutical...
This federal contract award with ID SPE2DX15D3108|SPE2DX24F25QL was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,329.26 firm fixed-price delivery order is for CARAFATE 1 GM/10 ML SUSP 420ML, a pharmaceutical product. The award is not associated with a set-aside program and represents an open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999...
This federal contract award, SPE2DB22D2206|SPE2DB24FHN43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,549.88 firm fixed-price delivery order contract is for the supply of Carafate 1 gm/10 ml suspension, a medication used to treat certain stomach and esophageal conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award is a Delivery Order worth $2,320.37 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Sucralfate 1 GM Tablets in quantities of 90s. It is an open-competition contract with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a wide range...
This federal contract award, with ID SPE2DB20D2104|SPE2DB22FS64F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,876.04 firm fixed price delivery order is for the supply of 4,557,126,338 units of Carafate 1 GM/10 ML suspension, a medication used to treat stomach and duodenal ulcers. The award is not associated with any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,215.64 firm fixed-price delivery order contract is for the supply of Sucralfate 1 GM tablets, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of October 31, 2023 and does not have a set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $1,239.18 firm fixed-price delivery order is for the supply of 4,560,242,783 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has an ultimate completion date of March 14, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $31,577.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,217,345 units of Sucralfate 1 GM Tablet 90S, a pharmaceutical product. The contract has an ultimate completion date of September 19, 2023 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,974.12 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...